Literature DB >> 12163572

Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Michael Weik1, Jens Modrof, Hans-Dieter Klenk, Stephan Becker, Elke Mühlberger.   

Abstract

The nucleocapsid protein VP30 of Ebola virus (EBOV), a member of the Filovirus family, is known to act as a transcription activator. By using a reconstituted minigenome system, the role of VP30 during transcription was investigated. We could show that VP30-mediated transcription activation is dependent on formation of a stem-loop structure at the first gene start site. Destruction of this secondary structure led to VP30-independent transcription. Analysis of the transcription products of bicistronic minigenomes with and without the ability to form the secondary structure at the first transcription start signal revealed that transcription initiation at the first gene start site is a prerequisite for transcription of the second gene, independent of the presence of VP30. When the transcription start signal of the second gene was exchanged with the transcription start signal of the first gene, transcription of the second gene also was regulated by VP30, indicating that the stem-loop structure of the first transcription start site acts autonomously and independently of its localization on the RNA genome. Our results suggest that VP30 regulates a very early step of EBOV transcription, most likely by inhibiting pausing of the transcription complex at the RNA structure of the first transcription start site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163572      PMCID: PMC136988          DOI: 10.1128/jvi.76.17.8532-8539.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Characterization of the L gene and 5' trailer region of Ebola virus.

Authors:  V E Volchkov; V A Volchkova; A A Chepurnov; V M Blinov; O Dolnik; S V Netesov; H Feldmann
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

2.  Interactions of Marburg virus nucleocapsid proteins.

Authors:  S Becker; C Rinne; U Hofsäss; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

3.  Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.

Authors:  E Mühlberger; B Lötfering; H D Klenk; S Becker
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 4.  Filovirus diseases.

Authors:  C J Peters; A S Khan
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 5.  Classification, structure, and replication of filoviruses.

Authors:  H Feldmann; M P Kiley
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

6.  Termini of all mRNA species of Marburg virus: sequence and secondary structure.

Authors:  E Mühlberger; S Trommer; C Funke; V Volchkov; H D Klenk; S Becker
Journal:  Virology       Date:  1996-09-15       Impact factor: 3.616

7.  Sequence and structural elements at the 3' terminus of bovine viral diarrhea virus genomic RNA: functional role during RNA replication.

Authors:  H Yu; C W Grassmann; S E Behrens
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription.

Authors:  D Harrich; C Ulich; R B Gaynor
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

Authors:  E Mühlberger; M Weik; V E Volchkov; H D Klenk; S Becker
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination.

Authors:  R W Hardy; S B Harmon; G W Wertz
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  70 in total

1.  The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Authors:  Takeshi Noda; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter.

Authors:  Simone Bach; Jana-Christin Demper; Arnold Grünweller; Stephan Becker; Nadine Biedenkopf; Roland K Hartmann
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

3.  Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association.

Authors:  Bettina Hartlieb; Tadeusz Muziol; Winfried Weissenhorn; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

4.  Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.

Authors:  Takeshi Noda; Shinji Watanabe; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.

Authors:  Sven Enterlein; Viktor Volchkov; Michael Weik; Larissa Kolesnikova; Valentina Volchkova; Hans-Dieter Klenk; Elke Mühlberger
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

7.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

8.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

9.  Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.

Authors:  Philipp A Ilinykh; Bersabeh Tigabu; Andrey Ivanov; Tatiana Ammosova; Yuri Obukhov; Tania Garron; Namita Kumari; Dmytro Kovalskyy; Maxim O Platonov; Vasiliy S Naumchik; Alexander N Freiberg; Sergei Nekhai; Alexander Bukreyev
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior.

Authors:  Kristina Brauburger; Yannik Boehmann; Verena Krähling; Elke Mühlberger
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.